Cardiovascular diseases, although widely screened through electrocardiograms, often remain undetected or misdiagnosed due to the difficulty in accurate interpretation, leading to their discovery at advanced stages with severe complications. Consequently, they stand as a significant threat globally, ranking as the leading cause of death worldwide and the second leading cause in Japan. Korbato Health's AI, leveraging its expertise in cardiology along with extensive data and groundbreaking AI development technology, enhances diagnostic accuracy significantly. Korbato Health’s diagnostic AI will enable the early detection and treatment of asymptomatic cardiovascular diseases, dramatically reducing the number of patients developing severe complications and contributing to both public health and healthcare economics.